Professor Alastair Greystoke
prof-ali-g.bsky.social
Professor Alastair Greystoke
@prof-ali-g.bsky.social
Professor of Precision Oncology at Newcastle and Clinical Director NE England Genomic Medicine Service. Interests include drug development especially in thoracic malignancy; biomarkers including cfDNA and treatment of older patients with cancer
With apologies to Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 for ignorance looks like similarly to England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 tepotinib available independent of line; although I would recommend as 1st line treatment as discussed
December 11, 2024 at 9:25 PM
How to get to emergency presentation patients?
Modelling of ability to “turn off” tumour analysis for some patients
Guidelines on above for Genomic labs /Pathology/Oncology
November 25, 2024 at 4:13 PM
We delivered a cost-effective national service with improvements in TAT and patient care. Questions still to be answered include
Impact on treatment and outcomes
How to move to business as usual?
How to integrate results with pathology and clinical notes?
November 25, 2024 at 4:13 PM
Me please 🫡
November 18, 2024 at 6:51 PM
Essays funded by @astrazeneca.bsky.social

Don’t think any of others here yet

@newcastleuni.bsky.social
November 18, 2024 at 8:54 AM
Need somebody to set-up one of those useful starter packs to find us all and start the conversation @bsky.app . Need to get BTOG and Professor P over here too 😀
November 16, 2024 at 11:18 AM